• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者血浆中环孢素游离分数的个体内和个体间变异性。

Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.

作者信息

Lindholm A, Henricsson S

机构信息

Department of Clinical Pharmacology, Huddinge Hospital, Sweden.

出版信息

Ther Drug Monit. 1989 Nov;11(6):623-30. doi: 10.1097/00007691-198911000-00002.

DOI:10.1097/00007691-198911000-00002
PMID:2595741
Abstract

The protein binding of cyclosporine (CyA) in plasma was studied in serial samples for 6 months after transplantation in 66 renal transplant recipients. Analysis was performed with a recently developed method of equilibrium dialysis in steel chambers. Among the 1,848 samples, the free fraction ranged from 0.5 to 4.2%, with a median of 1.30%. The free fraction of CyA was highest immediately after transplantation (1.66 +/- 0.49%). Diabetics had a higher free fraction of CyA than nondiabetics during the first 2 weeks after transplantation. A weak, but significant, covariation was observed between the serum concentration of albumin or bilirubin and the free fraction of CyA (r = -0.47 and r = 0.39, respectively; p less than 0.01). There was also a significant correlation between serum HDL cholesterol (r = -0.39 to -0.48; p less than 0.01), as well as apolipoprotein A1 (r = -0.35 to -0.49; p less than 0.01), and the free fraction of CyA. A significant drop in the free fraction of CyA was observed immediately prior to acute rejection episodes as compared with 1 week earlier (p less than 0.01), but there was no difference in the free fraction of CyA between patients who lost their graft and those who did not. There was an overall eightfold variation in the free fraction of CyA in plasma, with an up to fivefold intraindividual variation and a 2.3-fold variation in the mean free fraction between individuals. A significant covariation was observed between the free fraction of CyA and the concentration of binding proteins in plasma, as well as factors such as time after transplantation, diagnosis, and clinical events.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在66例肾移植受者移植后的6个月内,对其连续样本中的环孢素(CyA)血浆蛋白结合情况进行了研究。采用一种最近开发的在钢制腔室中进行平衡透析的方法进行分析。在1848份样本中,游离分数范围为0.5%至4.2%,中位数为1.30%。移植后即刻CyA的游离分数最高(1.66±0.49%)。在移植后的前2周,糖尿病患者的CyA游离分数高于非糖尿病患者。观察到血清白蛋白或胆红素浓度与CyA游离分数之间存在微弱但显著的协变关系(r分别为 -0.47和r = 0.39;p < 0.01)。血清高密度脂蛋白胆固醇(r = -0.39至 -0.48;p < 0.01)以及载脂蛋白A1(r = -0.35至 -0.49;p < 0.01)与CyA游离分数之间也存在显著相关性。与1周前相比,急性排斥反应发作前即刻观察到CyA游离分数显著下降(p < 0.01),但移植肾失功患者与未失功患者的CyA游离分数并无差异。血浆中CyA的游离分数总体有八倍的变化,个体内变化高达五倍,个体间平均游离分数变化为2.3倍。观察到CyA游离分数与血浆中结合蛋白浓度以及移植后时间、诊断和临床事件等因素之间存在显著协变关系。(摘要截短至250字)

相似文献

1
Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.肾移植受者血浆中环孢素游离分数的个体内和个体间变异性。
Ther Drug Monit. 1989 Nov;11(6):623-30. doi: 10.1097/00007691-198911000-00002.
2
Monitoring of the free concentration of cyclosporine in plasma in man.人体血浆中环孢素游离浓度的监测。
Eur J Clin Pharmacol. 1991;40(6):571-5. doi: 10.1007/BF00279972.
3
Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.血浆脂质对肾移植患者环孢素药代动力学的影响及其与血浆泼尼松龙水平的关系。
J Pharm Pharmacol. 2006 Sep;58(9):1193-200. doi: 10.1211/jpp.58.9.0005.
4
A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients.环孢素A在10名日本肾移植患者中的初步药代动力学研究。
Int J Clin Pharmacol Ther Toxicol. 1987 Aug;25(8):438-42.
5
A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.一种解释环孢素A在人血中血-浆分布的模型。
J Pharmacobiodyn. 1990 Jan;13(1):20-9. doi: 10.1248/bpb1978.13.20.
6
Renal allograft immunosuppression. IV. Comparison of lipid and lipoprotein profiles in blood using double and triple immunosuppressive drug combinations.
Transpl Int. 1991 Sep;4(3):130-5.
7
A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.肾移植后环孢素浓度与其治疗效果及毒性关系的前瞻性研究。
Br J Clin Pharmacol. 1990 Sep;30(3):443-52. doi: 10.1111/j.1365-2125.1990.tb03796.x.
8
The effect of ethanol on serum cyclosporine A levels in renal transplant recipients.
Am J Kidney Dis. 1987 Aug;10(2):133-5. doi: 10.1016/s0272-6386(87)80045-8.
9
[Study of 54 renal allograft recipients in the cyclosporin A era. What influences acute rejection episode and long-term graft survival?].
Nihon Hinyokika Gakkai Zasshi. 1992 Dec;83(12):1970-7. doi: 10.5980/jpnjurol1989.83.1970.
10
Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection.环孢素治疗的肾移植受者在排斥反应期间自然杀伤细胞活性增加。
Hum Immunol. 1987 Jun;19(2):139-49. doi: 10.1016/0198-8859(87)90101-7.

引用本文的文献

1
Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.使用液相色谱-串联质谱法进行免疫抑制剂治疗药物监测的替代基质
Bioanalysis. 2015;7(8):1037-58. doi: 10.4155/bio.15.35.
2
Distribution of cyclosporin in organ transplant recipients.环孢素在器官移植受者体内的分布。
Clin Pharmacokinet. 2002;41(9):615-37. doi: 10.2165/00003088-200241090-00001.
3
Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.高脂血症对硝苯地平在大鼠体内药代动力学的影响。
Pharm Res. 1999 Feb;16(2):309-13. doi: 10.1023/a:1018896912889.
4
The binding of cyclosporin A to human plasma: an in vitro microdialysis study.
Pharm Res. 1996 Apr;13(4):622-7. doi: 10.1023/a:1016066609489.
5
Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.肾病综合征患儿及肾移植患儿的环孢素药代动力学
Eur J Clin Pharmacol. 1994;47(1):61-5. doi: 10.1007/BF00193480.
6
Monitoring of the free concentration of cyclosporine in plasma in man.人体血浆中环孢素游离浓度的监测。
Eur J Clin Pharmacol. 1991;40(6):571-5. doi: 10.1007/BF00279972.
7
Therapeutic monitoring of cyclosporin--an update.
Eur J Clin Pharmacol. 1991;41(4):273-83. doi: 10.1007/BF00314952.
8
Optimisation of immunosuppressive therapy using pharmacokinetic principles.
Clin Pharmacokinet. 1992 Nov;23(5):380-90. doi: 10.2165/00003088-199223050-00004.